Patients who received Tramadol preoperatively for total shoulder replacement had a reduced risk of complications, resource use, infection and revision as compared to patients who were given traditional opioids.
John M. Kopriva MD, and co-workers used IBM Watson Health Marketscan to conduct a retrospective study of 29,454 patient data who had undergone primary TSA between 2009 and 2018. Researchers categorized patients into four groups: opioid naïve (50.8%, n = 14,953), tramadol (7.5%, n = 2,214), traditional opioids (35.5%, n = 10,462) and
